New results from the UNITED trial: smallmargin, weekly adaptive MRlinac treatment for glioblastoma significantly cuts normal brain dose (V60Gy ↓ from 146 - 157 → 84 - 93 cm³) and lowers brainstem/optic chiasm dose while maintaining target coverage. www.sciencedirect.com/science/arti...

Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac: UNITED trial Organs-at-Risk Sparing

To assess the dosimetric impact to organs-at-risk (OARs) and target coverage of a small margin weekly adaptive treatment for glioblastoma delivered on…

sciencedirect.com

Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! Georgios Tsekas from the NKI, presents Direct-to-treatment MRI-guided prostate RT using a generic patient-agnostic reference plan. Register on the MR-Linac Consortium Member Portal. #ProgressThroughCollaboration

There is still time to enter the MRgRT Spotlight competition! Don't miss out! members.mrlconsortium.org/event/mr-lin... #ProgressThroughCollaboration

Behind the MR‑Linac Consortium's progress is a group dedicated to advancing what’s possible in cancer care. The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.

Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.

Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.

Abstract submissions for the MR‑Linac Consortium Meeting 2026 are now open! We welcome your research and insights as we prepare for an exciting gathering in Montreal. Submit your abstract today via the link in your emails or on the member portal. lnkd.in/ef3TrgGS #ProgressThroughCollaboration

Ready to spotlight your expertise in MR-guided Radiotherapy (MRgRT)? We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡 Submit your entry today! lnkd.in/e3cc6-2k

Radiographer-led adaptive #MRgRT workflows are reshaping radiotherapy, streamlining processes, and improving patient experience. Hear Charlie Tran from GenesisCare Australia : lnkd.in/erTKBt6C #ProgressThroughCollaboration mrlconsortium.org

Celebrating Global Collaboration in MR-Linac Research! The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy. Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq

At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!

We are thrilled that Rad Chat joined us at the MR-Linac Consortium meeting! Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes

Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.

The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.

📄 This MOMENTUM study highlights the safety and tolerability of MRI-guided SBRT for liver metastases, showing promising results in maintaining disease control with manageable side effects. Patients reported a stable quality of life throughout treatment. lnkd.in/eN8sEzmz #MOMENTUM #LiverCancer

www.mrlconsortium.org #ProgressThroughCollaboration

Research from UTSW explores how PSMA-PET imaging can guide adaptive SABR in high-risk prostate cancer—refining tumor boosts based on response, without adding treatment time. MR-Linac and CBCT systems can offer practical paths to personalized, biology-driven radiotherapy. lnkd.in/e4pHnZg2

We’re thrilled to announce that the speaker lineup for the MR-Linac Consortium Meeting this November is confirmed! Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.

This study explores the feasibility and early outcomes of MR-guided stereotactic ablative radiotherapy (MRgSTAR) for patients with synchronous oligometastatic prostate cancer (OMPC). ✅ 100% 3-year overall survival ✅ 95.2% progression-free survival www.frontiersin.org/journals/onc...

Frontiers | Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer

ObjectivesTo prospectively investigate the feasibility, toxicity, and preliminary clinical outcomes of magnetic resonance (MR)-guided stereotactic total abla...

frontiersin.org

This retrospective analysis of five patients treated in the MOMENTUM study highlights that daily MR-adaptation reduces dose variability and OAR exposure compared to MR-guided plans alone for cervical cancer. #CervicalCancer #MOMENTUM medicaljournalssweden.se/actaoncologi...

www.mrlconosrtium.org

🚨A recent study leveraging MOMENTUM’s extensive dataset underlines that online adaptive MR-guided radiotherapy (MRgRT) shows promise for patients with non-metastatic pancreatic cancer. ✅ Maintained quality of life ✅ Significant symptom improvement at 6 months www.redjournal.org/article/S036...

Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy

Online adaptive magnetic resonance guided radiation therapy (MRgRT) using a hybrid magnetic resonance imaging and linear accelerator enables stereotactic ablative radiation doses to pancreatic tumors....

redjournal.org

Advancing MR-Guided Radiotherapy in Esophageal Cancer A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.

A simplified online adaptive workflow for long-course magnetic resonance-guided radiotherapy in esophageal cancer

Since the publication of the landmark CROSS trial in 2012 [1], neoadjuvant chemoradiotherapy has become a cornerstone in the curative treatment of esophageal cancer in much of the western world. The r...

phiro.science

Researchers in Nijmegen, Netherlands, have created an open-access online tool for early economic evaluation. This tool provides insights into the cost-effectiveness of MRIgRT. lnkd.in/e2sRxFRs Users can input their own data lnkd.in/erDkxXpF www.mrlconsortium.org hashtag#ProgressThroughCollaboration

www.mrlconsortium.org #ProgressThroughCollaboration

Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social

🗓️Is it time to retire the PTV concept? In this article, members of the MR-Linac Consortium in the Netherlands discuss advancements in online adaptive radiation therapy (RT) and its implications for planning target volume margins. 📊 www.redjournal.org/article/S036...

Toward the End of Planning Target Volume Margins With Online Adaptive Radiation Therapy

Radiation therapy aims to cure patients by delivering the prescribed dose to the tumor with high precision. In the presence of positioning uncertainties, the question arises how to ensure that the act...

redjournal.org

This study from Brescia compared Elekta Unity with Accuray Radixact outcomes for oropharyngeal cancer treatment. It shows that daily ATS workflow for treatment is feasible and well-tolerated, with potential advantages compared to helical tomotherapy. www.ctro.science/article/S240...

Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: Preliminary outcomes and comparison with helical tomotherapy

Oropharyngeal squamous cell carcinoma (OPSCC) is among the ten most common cancers worldwide and its incidence is growing due to increased exposure to major risk factors, including human papilloma vir...

ctro.science